VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 80 filers reported holding VERASTEM INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5 | 0.0% | 12,740 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 12,740 | -49.1% | 0.00% | – |
| Q3 2022 | $21,000 | +31.2% | 25,005 | +75.5% | 0.00% | – |
| Q2 2022 | $16,000 | -73.3% | 14,248 | -66.1% | 0.00% | – |
| Q1 2022 | $60,000 | -93.0% | 42,070 | -89.9% | 0.00% | – |
| Q4 2021 | $858,000 | +290.0% | 418,458 | +483.3% | 0.00% | – |
| Q3 2021 | $220,000 | -25.4% | 71,744 | -0.9% | 0.00% | – |
| Q2 2021 | $295,000 | -16.9% | 72,394 | -49.6% | 0.00% | – |
| Q1 2021 | $355,000 | +198.3% | 143,628 | +157.1% | 0.00% | – |
| Q4 2020 | $119,000 | +25.3% | 55,860 | -28.6% | 0.00% | – |
| Q3 2020 | $95,000 | -43.5% | 78,267 | -20.3% | 0.00% | – |
| Q2 2020 | $168,000 | +16700.0% | 98,157 | +21761.2% | 0.00% | – |
| Q4 2019 | $1,000 | -88.9% | 449 | -93.4% | 0.00% | – |
| Q3 2019 | $9,000 | -96.9% | 6,829 | -96.4% | 0.00% | – |
| Q2 2019 | $289,000 | +62.4% | 191,811 | +218.2% | 0.00% | – |
| Q1 2019 | $178,000 | +79.8% | 60,282 | +103.4% | 0.00% | – |
| Q4 2018 | $99,000 | -77.1% | 29,634 | -50.3% | 0.00% | – |
| Q3 2018 | $432,000 | +1500.0% | 59,638 | +1437.5% | 0.00% | – |
| Q2 2018 | $27,000 | – | 3,879 | +10982.9% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 35 | -96.1% | 0.00% | – |
| Q3 2017 | $4,000 | 0.0% | 900 | -70.9% | 0.00% | – |
| Q2 2016 | $4,000 | – | 3,092 | +1446.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 200 | -98.4% | 0.00% | – |
| Q3 2015 | $13,000 | +160.0% | 12,698 | +1778.4% | 0.00% | – |
| Q2 2015 | $5,000 | -70.6% | 676 | -59.1% | 0.00% | – |
| Q1 2015 | $17,000 | -43.3% | 1,654 | -49.8% | 0.00% | – |
| Q4 2014 | $30,000 | +7.1% | 3,293 | -5.9% | 0.00% | – |
| Q3 2014 | $28,000 | -52.5% | 3,498 | -46.4% | 0.00% | – |
| Q2 2014 | $59,000 | +18.0% | 6,529 | +31.7% | 0.00% | – |
| Q1 2014 | $50,000 | -16.7% | 4,958 | -9.9% | 0.00% | – |
| Q4 2013 | $60,000 | -57.1% | 5,502 | -52.8% | 0.00% | – |
| Q3 2013 | $140,000 | +1300.0% | 11,657 | +1446.0% | 0.00% | – |
| Q2 2013 | $10,000 | – | 754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |